CROs/Service Providers

Crystal3 Labs acquired by Vithalbhai Dhaduk

Monday, December 19, 2011 10:42 AM

Crystal3 Labs, a cGMP contract research organization based in Boca
Raton, FL, has been acquired by an individual investor, Vithalbhai Dhaduk, M.D., of Fargo, ND. Financial terms of the transaction were not disclosed. The company will also change its name to Global Pharma Analytics.

More... »

Icon boosts its presence in Asia with acquisition of Chinese CRO BeijingWits Medical Consulting

Monday, December 19, 2011 10:13 AM

Now that many mid-tier CROs have been acquired by either equity investment firms or other CROs and the trend has slowed, a new form of consolidation is emerging. Robust CROs are rounding out their offerings with small but strategic acquisitions to make them bigger, stronger and more complete. The ultimate goal: to continue winning lucrative strategic outsourcing agreements from sponsors.  

More... »

Charles River provides financial guidance for 2012

Thursday, December 15, 2011 02:59 PM

Charles River Laboratories International has provided guidance for 2012 and updated guidance for 2011. James C. Foster, Chairman, president and chief executive officer, said, “We made significant progress in 2011 on our four key initiatives, which include operating margin expansion, improved free cash flow, disciplined investment in existing growth businesses, and returning value to shareholders. In 2012, we will maintain our focus on these initiatives and on stimulating sales growth.”

More... »

Hill steps down as CEO following closing of PPD acquisition

Thursday, December 15, 2011 02:45 PM

Raymond Hill has stepped down as CEO of PPD, less than three months after taking the top post at the U.S.-based global CRO, according to a report from PharmaTimes. The announcement followed last week’s completion of PPD’s acquisition by affiliates of global investment firms The Carlyle Group and Hellman & Friedman and the company officially being taken private.

More... »

Covidien to launch spin-off pharmaceuticals business

Thursday, December 15, 2011 02:27 PM

Covidien, a global provider of healthcare products, plans to spin off its pharmaceuticals business into a standalone public company.

More... »

CROs form Asia CRO Alliance

Thursday, December 15, 2011 01:43 PM

Six Asian CROs have founded the Asia CRO Alliance (ACA) to combine regional expertise and provide integrated services across Asia. According to the ACA web site, it is the first and only alliance of niche, regional CROs in Asia to partner to enhance clinical research inAsia.

More... »

Molecular Imaging partners with Dana-Faber Cancer Institute

Thursday, December 15, 2011 08:15 AM

Molecular Imaging has entered into a licensing agreement with Dana-Farber Cancer Institute to access a substantial number of luciferase-enabled cancer cell lines developed at Dana-Farber. Access to these lines expands Molecular Imaging’s ability to apply bioluminescent imaging technology to a broad array of cancer disease models, including expanded capability in various leukemias, multiple myeloma, triple-negative breast cancer, glioma and melanoma.  

More... »

Clarient, ACORN collaborate to improve cancer treatment

Wednesday, December 14, 2011 12:22 PM

Clarient, a GE Healthcare company, and ACORN Research have formed a strategic collaboration around molecular testing of tumor samples. The agreement will establish a standardized testing protocol across the ACORN network of oncology community practices and hospitals with treatment guidelines and clinical trial opportunities. These processes have the potential to improve oncology treatment and research that aim to deliver targeted treatments based on the specific genetic markers for each patient.

More... »

Prestwick, Pharma Plexus form strategic alliance

Tuesday, December 13, 2011 11:44 AM

Prestwick Chemical, a chemical services company for the life sciences industry, has formed a strategic alliance with Pharma Plexus Holland, a provider of pharmaceutical optimization and development services. The two companies will work together on a significant lead optimization project recently won from a major pharmaceutical company.

More... »

Baxter to acquire Synovis for $260 million

Tuesday, December 13, 2011 11:30 AM

Baxter International and Synovis Life Technologies have reported a definitive agreement for Baxter to acquire Synovis, a provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures. The acquisition complements and will expand the portfolio of Baxter's regenerative medicine and biosurgery franchise, which includes a number of devices and biological products for hemostasis, tissue sealing and adherence.

More... »